BharatBiotech’s Covaxin is now available for children of age 6+

The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12.

The Drugs Controller General of India (DCGI) has given BharatBiotech’s Covaxin restricted emergency use authorisation. This vaccine can now be used for children between the ages of 6 to 12. Along with Covaxin, Union Health Minister Mansukh Mandaviya announced the approval of Corbevax and ZyCov-D vaccines for children.

This action is taken on the recommendation of the Subject Expert Committee (SEC) on Covid-19 by the Central Drugs Standard Control Organisation or CDSCO. The SEC had last week received applications from BharatBiotech’s Covaxin (for age group 6 to 12) and from Biological E’s Corbevax (for age 5 to 12).

The SEC gave BharatBiotech the no-objection certificate after a two-month-long deliberation on the topic. The DCGI has also asked BharatBiotech to share their safety data and data on adverse events twice every month for 2 months. After these two months, the vaccine maker can monthly send 1 report for 5 consecutive months. 

In December 2021 the DCGI had given Emergency Use Listing (EUL) to Covaxin to be used for ages 12 to 18. Corbevax on the other hand has been used for the age group 12 to 14. Even Zydus Cadila’s two-dose regimen ZycovD vaccine against Covid-19 has been approved for children over the age of 12 years. ZycovD showed a 66.6% efficacy in the interim analysis during Phase 3 clinical trials. 

The vaccination drive started on March 1st for people above the age of 60 years. A month later, on April 1st, the vaccination drive began for people over the age of 45. From May 1st onwards, a vaccination drive for every adult (18 years of age) began. Next came the age group of 15 to 18, for whom the vaccination phase began on January 3rd.

Tags : #BharatBiotech #Covaxin #vaccination #Children-Vaccination #vaccine #Covid-19 #Corbevax #Zycov-D #UnionHealthMinister #MansukhMandaviya #smitakumar #medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

NephroPlus Sets Guinness World Record & India Book of Records Title for Largest Kidney Health Screening DriveMarch 12, 2025
India Choosing to Eat Healthy; Order Volumes Up by 60% for Nutritional ProductsMarch 12, 2025
Amrita students win first prize at DecodeX 2025 hackathonMarch 12, 2025
Why Millions Are Losing Their Sight to Glaucoma And How You Can Prevent ItMarch 12, 2025
Çelebi India Ranks 3rd Worldwide in Ground Handling Performance for Turkish CargoMarch 12, 2025
Advancing Road Safety Through Clear Vision: VARS 4.0 Sets Bold AgendaMarch 12, 2025
The Deadly Cost of the “Perfect Body”: When Diet Trends Turn FatalMarch 12, 2025
Lighthouse Canton’s LC GenInnov Global Innovation Fund Secures Investment from Kotak Mahindra Asset ManagementMarch 11, 2025
TTK Prestige Revolutionizes Cooking with Innovative AirFlip Two-in-One Air Fryer and GrillMarch 11, 2025
Rewriting Immunology: The Discovery That Could Replace Traditional AntibioticsMarch 11, 2025
Is Your Cooking Oil Poisoning You? The Truth About Seed OilsMarch 11, 2025
Think Before You Bite: How Fatty Foods Can Trigger Brain Damage in Just 3 DaysMarch 11, 2025
Ditch the Pills: The Secret to Beating Insomnia is in Your WorkoutMarch 11, 2025
The University of Tasmania invites applications for Master of Public HealthMarch 11, 2025
CBM India Celebrates International Women's Day with Free Eye Screening in HyderabadMarch 11, 2025
Is patriarchy petrifying governments to deliver on gender equality?March 11, 2025
Bihar Hosts Fifth State-Level Consultation on Glaucoma PreventionMarch 10, 2025
Global College of Pharmaceutical Technology Hosts GIPCON 2025: A Convergence of Innovation & ExpertiseMarch 10, 2025
TIPS FOR PARENTS TO COMBAT INCREASING OBESITY AMONG CHILDRENMarch 10, 2025
Medanta hosts the second edition of its annual women’s conclave – Medanta Shakti’25, Celebrating women’s achievements and raising awareness on late pregnancies March 10, 2025